NHS National Generic Pharmaceuticals Interim 2 2020

NHS National Generic Pharmaceuticals Interim 2 2020

Hospital only products – all regions: 1 February 2021 to 31 January 2022 Orals (plus non-parenterals) – all regions.

United Kingdom-Runcorn: Pharmaceutical products

2020/S 172-417114

Contract notice

Supplies

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: The NHS Commissioning Board (operating under the name of NHS England)
Postal address: 2nd Floor, Rutland House
Town: Runcorn
NUTS code: UK UNITED KINGDOM
Postal code: WA7 2ES
Country: United Kingdom
Contact person: David Ford
E-mail: david.ford1@nhs.net
Internet address(es):Main address: https://www.england.nhs.uk/

Address of the buyer profile: https://www.england.nhs.uk/

I.2)Information about joint procurement

The contract is awarded by a central purchasing body

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://health-family.force.com/s/Welcome
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: https://health-family.force.com/s/Welcome
Tenders or requests to participate must be submitted to the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at: https://health-family.force.com/s/Welcome

I.4)Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

NHS National Generic Pharmaceuticals Interim 2 2020

 

Reference number: CM/PHG/20/5619

II.1.2)Main CPV code

33600000 Pharmaceutical products

II.1.3)Type of contract

Supplies

II.1.4)Short description:

Hospital only products — all regions: 1 February 2021 to 31 January 2022 Orals (plus non-parenterals) – all regions: 1 March 2021 to 28 February 2022 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.

 

II.1.5)Estimated total value

Value excluding VAT: 75 071 028.00 GBP

II.1.6)Information about lots

This contract is divided into lots: yes
Tenders may be submitted for all lots
Maximum number of lots that may be awarded to one tenderer: 2
II.2)Description

II.2.1)Title:

Interim 2 2020 — Orals (+ Non-parenterals) — All Regions 1 March 2021 to 28 February 2022

 

Lot No: 2

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UK UNITED KINGDOM
Main site or place of performance:

Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points.

 

II.2.4)Description of the procurement:

NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months OJEU Reference number: [insert OJEU Reference number] Potential periods of call-offs under the framework agreement: Hospital only products — all regions: 1 February 2021 to 31 January 2022 Orals (plus non-parenterals) – All regions: 1 March 2021 to 28 February 2022.

 

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/03/2021
End: 28/02/2022
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: yes
Description of options:

This framework lot has options to extend for periods of up to a maximum of 36 months.

 

II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description

II.2.1)Title:

Interim 2 2020 — Hospital Only Products — All Regions 1 February 2021 to 31 January 2022

 

Lot No: 1

II.2.2)Additional CPV code(s)

33600000 Pharmaceutical products

II.2.3)Place of performance

NUTS code: UK UNITED KINGDOM
Main site or place of performance:

Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points.

 

II.2.4)Description of the procurement:

NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months potential periods of call-offs under the framework agreement: Hospital only products — all regions: 1 February 2021 to 31 January 2022 Orals (plus non-parenterals) – All regions: 1 March 2021 to 28 February 2022.

 

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Start: 01/02/2021
End: 31/01/2022
This contract is subject to renewal: no

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: yes
Description of options:

This framework lot has options to extend for periods of up to a maximum of 36 months.

 

II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2)Economic and financial standing

Selection criteria as stated in the procurement documents
III.1.3)Technical and professional ability
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract

III.2.2)Contract performance conditions:

See KPI’s in procurement documents.

 

III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure

IV.1.3)Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement
Framework agreement with several operators
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 06/10/2020
Local time: 13:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 04/01/2021

IV.2.7)Conditions for opening of tenders

Date: 06/10/2020
Local time: 13:00
Place:

Runcorn.

 

Information about authorised persons and opening procedure:

Commercial Medicines Unit employee.

 

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no

VI.2)Information about electronic workflows

Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used

VI.3)Additional information:

 

Responding to this notice: any supplier may be disqualified who does not respond to the following in the requisite manner:

1) Submission of expression of interest and procurement specific information

This procurement exercise will be conducted on the eTendering portal at https://health-family.force.com/s/Welcome

Candidates wishing to be considered for this procurement exercise must register and provide additional procurement specific information (if requested) through the eTendering portal as follows:

1.1) If not already registered, candidates should register on the eTendering portal at https://health-family.force.com/s/Welcome and click the link to register:

— agree to the user agreement,

— populate company details

1.2) Once registered, candidates must register interest as follows:

— log to the portal,

— select ‘Find Opportunities’ from the supplier home screen, use the ‘Sort by:’ facility to find this opportunity and select the bold blue title to select

— review opportunity details and click ‘Register Interest’

— as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity).

1.3) There is a supplier user guide on using the system and candidates can contact the Atamis helpdesk at support-health@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.

2) General supplier information. To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Government’s Supplier Registration Service (which has replaced sid4gov), as follows:

2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk and select ‘Register’ at the top of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun and Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.

2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.

2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the message function on the website.

Other contracting authorities

The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.

 

VI.4)Procedures for review

VI.4.1)Review body

Official name: The High Court
Postal address: Strand
Town: London
Postal code: WC2A 2LL
Country: United KingdomInternet address: https://www.gov.uk/courts-tribunals
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

01/09/2020